| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/02/2007 | CN1957084A Bone marrow-relevant cell participating the maintenance and/or repair of tissue |
| 05/02/2007 | CN1956719A Specific ppar excitant for treating negative energy equilibrium |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1954886A Application process of pig interleukin 2 and 6 gene expression plasmid anti-infectious preparation |
| 05/02/2007 | CN1954885A Preparation and application of compound pig interleukin gene anti-infections nano molecular preparation |
| 05/02/2007 | CN1954884A Preparation and application of anti-infectious immunity preparation of pig interleukin 6 gene and CpG molecular fusional |
| 05/02/2007 | CN1954878A Preparation method of ginger allicin immunity soft capsult |
| 05/02/2007 | CN1954823A Medical composite for eye and its preparation method and quality control method |
| 05/02/2007 | CN1313490C Segregative technique for purifying stimulating factor of recombined human beta lymphocyte |
| 05/02/2007 | CN1313481C Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/02/2007 | CN1313469C Novel derivative of flavone c-glycoside and composition containing the same |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
| 05/01/2007 | US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 05/01/2007 | US7211567 Administering kaempferol-3-glucoside orally in a food composition, in chewable tablet form or as a liquid, to a subject who suffers from pollinosis |
| 05/01/2007 | US7211260 Infectious bursitis vaccine |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
| 05/01/2007 | CA2244357C A novel pharmaceutical composition for inhalation containing cr 2039 (andolast) |
| 05/01/2007 | CA2154689C Improved immunotherapeutic composition |
| 05/01/2007 | CA2121497C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 04/26/2007 | WO2007047492A2 Increasing thymic output in hiv-negative patients with antiretrovirals |
| 04/26/2007 | WO2007046544A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 04/26/2007 | WO2007046411A1 Method for stabilization of isoxazole compound |
| 04/26/2007 | WO2007045980A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | WO2007045979A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 04/26/2007 | WO2007045469A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/26/2007 | WO2007045046A1 Treatment of hypersensitivity |
| 04/26/2007 | WO2007022813A3 A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
| 04/26/2007 | WO2007000671A3 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 04/26/2007 | WO2006097327A3 Soluble btnl2 protein useful to inhibit inflammatory disorders |
| 04/26/2007 | WO2006053121A3 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093427 Membrane-permeable NFAT inhibitory peptide |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092944 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 04/26/2007 | US20070092933 Production of multimeric fusion proteins using a c4bp scaffold |
| 04/26/2007 | US20070092516 Antibody preparation |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | US20070092506 Use of rapamycin and agents that inhibit B7 activity in immunomodulation |
| 04/26/2007 | US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses |
| 04/26/2007 | DE4332436B4 Cyclosporin enthaltende pharmazeutische Zusammensetzungen The cyclosporin-containing pharmaceutical compositions |
| 04/26/2007 | CA2626692A1 Treatment of hypersensitivity |
| 04/26/2007 | CA2626628A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | CA2626612A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 04/26/2007 | CA2626556A1 Antibody-based therapeutics with enhanced adcc activity |
| 04/26/2007 | CA2624925A1 Immunomodulation using placental stem cells |
| 04/26/2007 | CA2624617A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777217A1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 04/25/2007 | EP1776963A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/25/2007 | EP1776962A1 Vaccine |
| 04/25/2007 | EP1776957A2 Use of herpes vectors for tumor therapy |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776387A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 04/25/2007 | EP1776369A1 Thienopyridone carboxamides and their medical use |
| 04/25/2007 | EP1776366A1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors |
| 04/25/2007 | EP1776356A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1697371B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1697370B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1430133B1 A soluble toll-like receptor |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP1196182B9 Method for enhancing production performance in an animal |
| 04/25/2007 | EP0984023B1 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953783A Treatment of diseases |
| 04/25/2007 | CN1953759A Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
| 04/25/2007 | CN1952166A Important controlling gene PIX in anti-tumor immunological reaction |
| 04/25/2007 | CN1952135A Polynucleotide related to cell multiplication and its encoded polypeptide and application |
| 04/25/2007 | CN1951949A N-alkylated 1,6-bideoxyazaglucide compound, its synthesis method and uses |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951502A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/25/2007 | CN1951473A Quality control method of a Chinese medicinal injection |
| 04/25/2007 | CN1951455A Spine applied ointment with inflammation-diminishing and pain-relieving functions |
| 04/25/2007 | CN1951446A Externally applied medicine for treating dermatosis |